These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
471 related articles for article (PubMed ID: 15623604)
1. Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis is inhibited by Bcl-2 but restored by the small molecule Bcl-2 inhibitor, HA 14-1, in human colon cancer cells. Sinicrope FA; Penington RC; Tang XM Clin Cancer Res; 2004 Dec; 10(24):8284-92. PubMed ID: 15623604 [TBL] [Abstract][Full Text] [Related]
2. Sulindac sulfide-induced apoptosis is enhanced by a small-molecule Bcl-2 inhibitor and by TRAIL in human colon cancer cells overexpressing Bcl-2. Sinicrope FA; Penington RC Mol Cancer Ther; 2005 Oct; 4(10):1475-83. PubMed ID: 16227396 [TBL] [Abstract][Full Text] [Related]
3. The small-molecule Bcl-2 inhibitor HA14-1 interacts synergistically with flavopiridol to induce mitochondrial injury and apoptosis in human myeloma cells through a free radical-dependent and Jun NH2-terminal kinase-dependent mechanism. Pei XY; Dai Y; Grant S Mol Cancer Ther; 2004 Dec; 3(12):1513-24. PubMed ID: 15634644 [TBL] [Abstract][Full Text] [Related]
4. Involvement of proapoptotic molecules Bax and Bak in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced mitochondrial disruption and apoptosis: differential regulation of cytochrome c and Smac/DIABLO release. Kandasamy K; Srinivasula SM; Alnemri ES; Thompson CB; Korsmeyer SJ; Bryant JL; Srivastava RK Cancer Res; 2003 Apr; 63(7):1712-21. PubMed ID: 12670926 [TBL] [Abstract][Full Text] [Related]
5. Potent antileukemic interactions between flavopiridol and TRAIL/Apo2L involve flavopiridol-mediated XIAP downregulation. Rosato RR; Dai Y; Almenara JA; Maggio SC; Grant S Leukemia; 2004 Nov; 18(11):1780-8. PubMed ID: 15385934 [TBL] [Abstract][Full Text] [Related]
6. Reactive oxygen species regulate caspase activation in tumor necrosis factor-related apoptosis-inducing ligand-resistant human colon carcinoma cell lines. Izeradjene K; Douglas L; Tillman DM; Delaney AB; Houghton JA Cancer Res; 2005 Aug; 65(16):7436-45. PubMed ID: 16103097 [TBL] [Abstract][Full Text] [Related]
7. TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO. Deng Y; Lin Y; Wu X Genes Dev; 2002 Jan; 16(1):33-45. PubMed ID: 11782443 [TBL] [Abstract][Full Text] [Related]
8. Activation of ERK1/2 protects melanoma cells from TRAIL-induced apoptosis by inhibiting Smac/DIABLO release from mitochondria. Zhang XD; Borrow JM; Zhang XY; Nguyen T; Hersey P Oncogene; 2003 May; 22(19):2869-81. PubMed ID: 12771938 [TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of human melanoma is regulated by smac/DIABLO release from mitochondria. Zhang XD; Zhang XY; Gray CP; Nguyen T; Hersey P Cancer Res; 2001 Oct; 61(19):7339-48. PubMed ID: 11585775 [TBL] [Abstract][Full Text] [Related]
10. Defining characteristics of Types I and II apoptotic cells in response to TRAIL. Ozören N; El-Deiry WS Neoplasia; 2002; 4(6):551-7. PubMed ID: 12407450 [TBL] [Abstract][Full Text] [Related]
11. Bcl-2 inhibitors sensitize tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by uncoupling of mitochondrial respiration in human leukemic CEM cells. Hao JH; Yu M; Liu FT; Newland AC; Jia L Cancer Res; 2004 May; 64(10):3607-16. PubMed ID: 15150119 [TBL] [Abstract][Full Text] [Related]
12. X-linked inhibitor of apoptosis (XIAP) blocks Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis of prostate cancer cells in the presence of mitochondrial activation: sensitization by overexpression of second mitochondria-derived activator of caspase/direct IAP-binding protein with low pl (Smac/DIABLO). Ng CP; Bonavida B Mol Cancer Ther; 2002 Oct; 1(12):1051-8. PubMed ID: 12481428 [TBL] [Abstract][Full Text] [Related]
13. Ectopic overexpression of second mitochondria-derived activator of caspases (Smac/DIABLO) or cotreatment with N-terminus of Smac/DIABLO peptide potentiates epothilone B derivative-(BMS 247550) and Apo-2L/TRAIL-induced apoptosis. Guo F; Nimmanapalli R; Paranawithana S; Wittman S; Griffin D; Bali P; O'Bryan E; Fumero C; Wang HG; Bhalla K Blood; 2002 May; 99(9):3419-26. PubMed ID: 11964312 [TBL] [Abstract][Full Text] [Related]
14. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II. Ravi R; Bedi A Cancer Res; 2002 Aug; 62(15):4180-5. PubMed ID: 12154014 [TBL] [Abstract][Full Text] [Related]
15. Rottlerin sensitizes colon carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis via uncoupling of the mitochondria independent of protein kinase C. Tillman DM; Izeradjene K; Szucs KS; Douglas L; Houghton JA Cancer Res; 2003 Aug; 63(16):5118-25. PubMed ID: 12941843 [TBL] [Abstract][Full Text] [Related]
16. The caspase 9 inhibitor Z-LEHD-FMK protects human liver cells while permitting death of cancer cells exposed to tumor necrosis factor-related apoptosis-inducing ligand. Ozoren N; Kim K; Burns TF; Dicker DT; Moscioni AD; El-Deiry WS Cancer Res; 2000 Nov; 60(22):6259-65. PubMed ID: 11103780 [TBL] [Abstract][Full Text] [Related]
17. Ectopic expression of Bcl-2 and Bcl-xL inhibits apoptosis induced by TNF-related apoptosis-inducing ligand (TRAIL) through suppression of caspases-8, 7, and 3 and BID cleavage in human acute myelogenous leukemia cell line HL-60. Lamothe B; Aggarwal BB J Interferon Cytokine Res; 2002 Feb; 22(2):269-79. PubMed ID: 11911810 [TBL] [Abstract][Full Text] [Related]
18. Cotreatment with histone deacetylase inhibitor LAQ824 enhances Apo-2L/tumor necrosis factor-related apoptosis inducing ligand-induced death inducing signaling complex activity and apoptosis of human acute leukemia cells. Guo F; Sigua C; Tao J; Bali P; George P; Li Y; Wittmann S; Moscinski L; Atadja P; Bhalla K Cancer Res; 2004 Apr; 64(7):2580-9. PubMed ID: 15059915 [TBL] [Abstract][Full Text] [Related]
19. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells. Izeradjene K; Douglas L; Delaney A; Houghton JA Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455 [TBL] [Abstract][Full Text] [Related]
20. Proteasome inhibitors-mediated TRAIL resensitization and Bik accumulation. Zhu H; Guo W; Zhang L; Wu S; Teraishi F; Davis JJ; Dong F; Fang B Cancer Biol Ther; 2005 Jul; 4(7):781-6. PubMed ID: 16082182 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]